WORLD'S LARGEST MARKET RESEARCH RESOURCE — 1,519,265 REPORTS

 
 
• SEARCH FOR A REPORT

Viewing report

Search
Enter keywords, a title or a report id number below.
Advanced

• ORDER BY FAX

Order By Fax

• SELECT SITE CURRENCY

Select a currency for use throughout the site



  • Electronic (PDF) Information Icon
  • Enterprisewide Information Icon
Live Chat Live Help Software for Website

2012 Global Papillomavirus Diagnostics Market Outlook: Test Volumes, Sales Forecasts, and Supplier Shares by Country

Venture Planning Group (VPG), April 2012, Pages: 191

The report presents a detailed analysis of the Papillomavirus diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Papillomavirus definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:

- Hospitals
- Commercial/Private Labs
- Physician Offices
- Public Health Labs

In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Papillomavirus tests.

Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.

I. Introduction
II. HPV/Papillomavirus Worldwide Market and Technology Overview
A. Background
B. Diagnostic Tests: Pap Smear and HPV
C. Vaccines and Drugs
D. Emerging Diagnostic Technologies
III. France: Test Volume and Diagnostics Sales Forecasts by Market Segment
IV. Germany: Test Volume and Diagnostics Sales Forecasts by Market Segment
V. Italy: Test Volume and Diagnostics Sales Forecasts by Market Segment
VI. Japan: Test Volume and Diagnostics Sales Forecasts by Market Segment
VII. Spain: Test Volume and Diagnostics Sales Forecasts by Market Segment
VIII. UK: Test Volume and Diagnostics Sales Forecasts by Market Segment
IX. USA: Test Volume and Diagnostics Sales Forecasts by Market Segment
X. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
XI. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
XII. Competitive Assessments
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix
- DiaSorin
- Eiken Chemical
- Enzo Biochem
- Fujirebio
- Gen-Probe
- Hologic
- ID Biomedical
- Innogenetics/Solvay
- Ortho-Clinical Diagnostics/J&J
- Kreatech
- Life Technologies
- Lonza
- Nanogen/Elitech
- Novartis
- PerkinElmer
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens
- Takara Bio
- Thermo Fisher
- Wako

List of Tables
France: Pap Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
France: Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany: Pap Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany: Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy: Pap Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy: Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan: Pap Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan: Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecasts by Market Segment
Spain: Pap Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
Spain: Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecasts by Market Segment
UK: Pap Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
UK: Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecasts by Market Segment
USA: Pap Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
USA: Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecasts by Market Segment

Customers who bought this item also bought